These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20863965)

  • 1. [Treatment of ABPA: a place for voriconazole and omalizumab?].
    Mulliez P
    Rev Mal Respir; 2010 Sep; 27(7):670-2. PubMed ID: 20863965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rebound after ABPA treatment with voriconazole].
    Mulliez P; Croxo C; Saint-Georges FR
    Rev Mal Respir; 2010 Sep; 27(7):786-7. PubMed ID: 20863984
    [No Abstract]   [Full Text] [Related]  

  • 3. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
    Bandrés Gimeno R; Muñoz Martínez MJ
    Arch Bronconeumol; 2007 Jan; 43(1):49-51. PubMed ID: 17257565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    Erwin GE; Fitzgerald JE
    J Asthma; 2007 Dec; 44(10):891-5. PubMed ID: 18097869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab for treatment of ABPA exacerbations in CF patients.
    Lebecque P; Leonard A; Pilette C
    Pediatr Pulmonol; 2009 May; 44(5):516. PubMed ID: 19382216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Allergic broncho-pulmonary aspergillosis treated with voriconazole].
    Mulliez P; Croxo C; Roy-Saint Georges F; Darras A
    Rev Mal Respir; 2006 Feb; 23(1 Pt 1):93-4. PubMed ID: 16604033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perspectives on allergic bronchopulmonary aspergillosis].
    Germaud P; Pipet A
    Rev Mal Respir; 2007 May; 24(5):659-61. PubMed ID: 17519821
    [No Abstract]   [Full Text] [Related]  

  • 9. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach.
    Randhawa I; Chin T; Nussbaum E
    J Asthma; 2009 Jun; 46(5):445-7. PubMed ID: 19544162
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).
    Kanu A; Patel K
    Pediatr Pulmonol; 2008 Dec; 43(12):1249-51. PubMed ID: 19009619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic bronchopulmonary aspergillosis.
    Patterson K; Strek ME
    Proc Am Thorac Soc; 2010 May; 7(3):237-44. PubMed ID: 20463254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic bronchopulmonary aspergillosis: new therapeutic options].
    Germaud P; Pipet A
    Rev Mal Respir; 2010 Sep; 27(7):784-5. PubMed ID: 20863983
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Kaffarnik M; Utzolino S; Blaich A; Hopt UT
    Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
    Zirbes JM; Milla CE
    Pediatr Pulmonol; 2008 Jun; 43(6):607-10. PubMed ID: 18433040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
    Wong R; Wong M; Robinson PD; Fitzgerald DA
    Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
    Wark P
    Respir Med; 2004 Oct; 98(10):915-23. PubMed ID: 15481266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.